Analysts' Actions: AXP, MS, BLK, USB, CHK

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Abbott Laboratories ( AB) numbers raised at Goldman. Shares of ABT now seen reaching $59. Estimates also increased, to match the company's new guidance. Neutral rating.

Financial firm Access National ( ANCX) is upgraded to buy at TheStreet Ratings.

Agrium ( AGM) upgraded at JP Morgan to Overweight. Agriculture fundamentals are robust.

American Express ( AXP) removed from Top Picks at Citigroup. Shares of AXP now seen reaching $58. Estimates also lowered on Europe softness. Maintain Buy rating.

American Express estimates cut at Goldman through 2013. Company is releasing fewer reserves. Buy rating and $56 price target.

Amphenol ( APH) estimates, target lowered at Citigroup. Shares of APH now seen reaching $51. Estimates also lowered as defense spending trends remain clouded due to Washington. Buy rating.

Amphenol estimates, target cut at Credit Suisse. Shares of APH now seen reaching $49. Estimates also reduced, given weaker end-market demand. Outperform rating.

Amphenol estimates, target lowered at UBS. Shares of APH now seen reaching $46. Estimates also lowered as 4Q outlook impacted by Telecom/IT Datacom. Neutral rating.

Apollo ( APOL) estimates, target increased at Citigroup. Shares of APOL now seen reaching $50. Estimates also raised on positive outlook and regulatory concerns waning. Neutral rating.

Apollo estimates, target raised at Credit Suisse. Shares of APOL now seen reaching $52. Estimates also increased, given higher growth in starts. Outperform rating.

BlackRock ( BLK) estimates increased at Citigroup through 2012. NAVs partially offset by lower ST flows. Maintain $180 price target and Buy rating.

BlackRock estimates, target reduced at Credit Suisse. Shares of BLK now seen reaching $194. Estimates also cut, given lower net flows. Outperform rating.

Celestica ( CLS) downgraded at Ticonderoga from Buy to Neutral. Slower end-market demand could hurt growth. Company is also highly leveraged to Research in Motion.

Cheesecake Factory ( CAKE) numbers cut at Credit Suisse. Shares of CAKE now seen reaching $30. Estimates also reduced, as the company is struggling to leverage higher sales. Neutral rating.

Chesapeake Energy rated new Buy at Sterne Agee. CHK was initiated with a Buy rating. $40 price target. Company is cutting debt and liquids business should drive growth.

Cognizant ( CTSH) downgraded at Goldman to Neutral. Valuation call.

If you liked this article you might like

Take Xilinx' Rally Seriously

Are the Semis Now on Shaky Ground?

Are the Semis Now on Shaky Ground?

Xilinx, Arena Pharmaceuticals, Magellan Midstream: 'Mad Money' Lightning Round

'I Love the Down-and-Outers': Cramer's 'Mad Money' Recap (Thursday 7/13/17)